4//SEC Filing
Millar Kerri-Ann 4
Accession 0001209191-20-048212
CIK 0001645460other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 4:12 PM ET
Size
13.3 KB
Accession
0001209191-20-048212
Insider Transaction Report
Form 4
Millar Kerri-Ann
CHIEF FINANCIAL OFFICER
Transactions
- Tax Payment
Common Stock
2020-08-24−1,900→ 5,766 total - Award
Restricted Stock Units
2020-08-21+20,000→ 20,000 total→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2020-08-21+6,666→ 7,666 total - Award
Stock Option (right to buy)
2020-08-21+65,000→ 65,000 totalExercise: $19.87Exp: 2030-08-21→ Common Stock (65,000 underlying) - Exercise/Conversion
Restricted Stock Units
2020-08-21−6,666→ 13,334 total→ Common Stock (6,666 underlying)
Footnotes (4)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
- [F2]This stock option grant becomes exercisable in eight equal semi-annual installments beginning February 21, 2021.
- [F3]Each restricted stock unit award represents a contingent right to receive one share of common stock.
- [F4]Represents a restricted stock unit award granted on August 21, 2020. The restricted stock units vest in three equal annual installments beginning on August 21, 2020.
Documents
Issuer
Cue Biopharma, Inc.
CIK 0001645460
Entity typeother
Related Parties
1- filerCIK 0001739126
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 4:12 PM ET
- Size
- 13.3 KB